Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Tamir Biotechnology, Inc. | alfacell_10k-073109.htm |
| EX-32.1 - CERTIFICATION - Tamir Biotechnology, Inc. | ex32-1.htm |
| EX-31.2 - CERTIFICATION - Tamir Biotechnology, Inc. | ex31-2.htm |
| EX-31.1 - CERTIFICATION - Tamir Biotechnology, Inc. | ex31-1.htm |
| EX-23.2 - CONSENT OF KPMG LLP - Tamir Biotechnology, Inc. | ex23-2.htm |
| EX-10.51 - TERMINATION AGREEMENT - Tamir Biotechnology, Inc. | ex10-51.htm |
| EX-10.52 - AMENDMENT TO RETIREMENT AGREEMENT - Tamir Biotechnology, Inc. | ex10-52.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our
report on our audits of the financial statements of Alfacell Corporation as of
July 31, 2009 and 2008 and for each of the years in the three-year period ended
July 31, 2009 and on the statements of operations, changes in stockholders'
equity (deficiency) and cash flows for the period from August 24, 1981 (date of
inception) to July 31, 2009, included in this annual report on Form 10-K for the
year ended July 31, 2009, dated November 13, 2009 expressed an unqualified
opinion on those financial statements and included an explanatory paragraph
regarding the Company’s ability to continue as a going concern. We
consent to the incorporation by reference of our report in the Registration
Statements on Form S-8 (SEC File Nos. 33-81308, 333-110074 and 333-112866) and
on Form S-3 (SEC File No. 333-112865 and 333-136678) previously filed by the
Company with the Securities and Exchange Commission pursuant to the Securities
Act of 1933.
/s/ J.H.
Cohn LLP
Roseland,
New Jersey
November
13, 2009